Skip to main content
. 2018 Nov 16;3(11):15643–15652. doi: 10.1021/acsomega.8b02092

Table 2. Properties of the Examined IDPs in Disprot-pdb.

disport id name conf. number total cavity number druggable cavity number disorder percent (%) pcommon rmsd (Å)
1ZR9 zinc finger protein 593 20 46 4 52 0.72 ± 0.10 3.90 ± 0.84
1ZYI methylosome subunit pICln 15 74 22 58 0.74 ± 0.21 2.08 ± 0.68
2KOG vesicle-associated membrane 20 68 10 79 0.35 ± 0.23 4.32 ± 2.11
1HN3 cyclin-dependent kinase inhibitor 2A 20 40 6 100 0.72 ± 0.11 4.07 ± 0.86
2LM0.A protein AF9 chimera 10 55 10 100 0.79 ± 0.06 4.40 ± 0.88
1IVT lamin A/C 15 59 0 58 0.51 ± 0.35 1.38 ± 0.82
1FTT homeobox protein Nkx-2.1 20 51 0 74.2 0.52 ± 0.26 2.56 ± 1.57
1USS histone H1 10 40 0 93 0.52 ± 0.26 2.67 ± 1.20
1ANP atrial natriuretic factor 11 6 0 100 0.96 ± 0.03 1.94 ± 0.38
1KDX.B cyclic AMP-responsive element-binding protein 1 17 12 0 100 0.72 ± 0.17 1.83 ± 0.50
1TBA.A transcription initiation factor TFIID subunit 1 25 68 0 100 0.66 ± 0.23 2.83 ± 1.17
1VZS ATP synthase-coupling factor 6, mitochondrial 34 140 2 100 0.56 ± 0.21 2.94 ± 1.10
1WXL FACT complex subunit Ssrp1 30 65 0 100 0.54 ± 0.28 1.82 ± 1.16
2K7M gap junction α-5 protein 10 45 1 100 0.51 ± 0.27 3.72 ± 1.37
2LJ9 Calvin cycle protein CP12-2, chloroplastic 20 10 0 100 0.77 ± 0.11 4.45 ± 1.21